The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

The main endpoint in the study was the change from baseline ... reveals that mazdutide is in phase 2 outside China. Meanwhile, other companies looking at combined GLP-1/glucagon agonists include ...

The DPR was revised based on govt directives to integrate metro rail and road infrastructure. Intermediate ramps near Tambaram will provide access to the Outer Ring Road (ORR), and the elevated ...

SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of GPCR drug discovery, today announced ...

Pemvidutide has successfully completed a Phase 1 trial for a related liver disease but has yet to demonstrate efficacy in the target indication of MASH. Direct peers such as Akero Therapeutics and ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in lymphoma show the therapy can “leapfrog” the competition. The biotech ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Phase 1 started the overarching recovery process with a $100 million hazardous material cleanup, which involved more than 500 EPA personnel. During Phase 1, residents could have prepared for the ...

CAIRO – The first phase of the Israel-Hamas truce drew to a close on March 1, but negotiations on the next stage, which should secure a permanent ceasefire, have so far been inconclusive.

The board of Guardian Capital Group Limited (TSE:GCG.A) has announced that the dividend ... Looking forward, EPS could fall by 1.8% if the company can't turn things around from the last few ...